Market expansion Expand presence in Asia and Korea leveraging RT300 and Xcite2 launches at KIMES to reach large rehab markets and hospitals, signaling opportunity for regional distributors, training programs, and payer partnerships.

Clinical adoption Capitalize on strong clinical evidence base and therapy outcomes to target rehabilitation centers, long-term care facilities, and home healthcare providers with reimbursement support and clinician training services.

Strategic partnerships Leverage ongoing clinician, researcher, and payer collaborations to co-create value propositions, secure group purchasing commitments, and expand access through United Spinal Association discounts and similar alliances.

Cybersecurity diligence Address rising cybersecurity concerns from recent ransomware incident by offering security audits, certified backups, and vendor risk management to reassure hospitals and clinics and support procurement processes.

Product portfolio Cross-sell RT300 and Xcite2 capabilities to hospitals and therapy clinics by highlighting both system-wide neurorehabilitation benefits and task-specific movement training, backed by clinical training and ongoing customer service.